Evidence map›Paper›PMID 28769928›Full record

ArticleFrontiers in immunology2017

Anaphylatoxin C5a Regulates 6-Sulfo-LacNAc Dendritic Cell Function in Human through Crosstalk with Toll-Like Receptor-Induced CREB Signaling.

Anouk Zaal, Miranda Dieker, Manon Oudenampsen, Annelies W Turksma, Suzanne N Lissenberg-Thunnissen, Diana Wouters, S Marieke van Ham, Anja Ten Brinke

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anouk ZaalDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
Miranda DiekerDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
Manon OudenampsenDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
Annelies W TurksmaDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
Suzanne N Lissenberg-ThunnissenDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
Diana WoutersDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
S Marieke van HamDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
Anja Ten BrinkeDepartment of Immunopathology, Sanquin Research, Amsterdam, Netherlands.
University of Amsterdam · NLSanquin · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activation of antigen-presenting dendritic cells (DCs) and the complement system are essential early events in the immune defense against invading pathogens. Recently, we and others demonstrated immunological crosstalk between signaling from receptors recognizing complement activation products and PAMPs on DCs. This affects DC effector function, as demonstrated by the finding that C5a prevents induction of pro-inflammatory cytokines by toll-like receptor (TLR) ligands in human monocyte-derived DCs (moDCs). Here, we demonstrate that this regulatory crosstalk is specifically important in 6-sulfo LacNAc dendritic cells (slanDCs), the most pro-inflammatory DC subset found in human. C5aR and TLR signaling show profound interference in the ERK/p38/CREB1 signaling pathways. C5aR signaling accelerates TLR-induced CREB1 phosphorylation both in moDC and slanDC. This is key in the regulatory effect of C5a on pro-inflammatory DC maturation by mediating induction of IL-10, which subsequently inhibits pro-inflammatory cytokine production

Indexed as

6-sulfo LacNAc dendritic cellcomplementcrosstalkhumanIL-10LPSpro-inflammatory cytokinesR848

Identifiers

PMID28769928
PMCPMC5509794
OpenAlexW2734546985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.